1. Introduction: Nigeria’s Heavy Burden of Sickle Cell Disease

Sickle cell disease (SCD) represents one of the most significant genetic health challenges facing Nigeria and the African continent. Nigeria bears the greatest burden of sickle cell disease in sub-Saharan Africa, with an estimated 150,000 babies born with the condition annually, making it the sixth leading cause of childhood death in the country. The country’s high prevalence is attributed in part to the protective effect of the sickle cell trait against malaria, which has maintained the gene frequency in malaria-endemic regions.

The disease results from a single base substitution in the gene encoding the human beta-globin subunit, causing the replacement of glutamic acid by valine at the sixth position of the beta-globin chain. This seemingly small change produces haemoglobin S (HbS), which, when deoxygenated, polymerises and causes red blood cells to assume a characteristic sickle shape. The clinical consequences include haemolytic anaemia, recurrent painful vaso-occlusive crises, chronic end-organ damage, and significantly reduced life expectancy.

In Nigeria, the challenges of managing SCD are compounded by limited healthcare resources, high treatment costs, and the competing priorities of infectious diseases such as malaria and HIV/AIDS. Conventional treatments including hydroxyurea, folic acid supplementation, penicillin prophylaxis, and blood transfusions are often expensive and inaccessible to many families, with patients frequently spending more than 25% of their monthly income on healthcare.

Against this backdrop, traditional medicine has remained a cornerstone of SCD management across Nigerian communities. The widespread use of herbal remedies, spiritual interventions, and holistic approaches reflects both the cultural heritage of Nigerian peoples and the economic realities facing families living with this chronic condition.

2. Conceptualisation of Sickle Cell Disease in Nigerian Traditional Thought

Understanding the traditional management of sickle cell anaemia requires appreciation of how the condition is perceived within Nigerian cultural frameworks. The conceptualisation of health and disease in African Traditional Medicine is far more sophisticated than many biomedical scientists may assume.

Across various Nigerian ethnic groups, sickle cell anaemia is recognised as a chronic, enduring condition with spiritual and social dimensions:

Ethnic GroupTraditional TermConceptualisation
Hausa-Fulani“Sankara-miji“Perceived as “paranormal” and incurable
Yoruba“Abiku“Umbrella term encompassing sickle cell anaemia, associated with spirit children who repeatedly die and are reborn
Igbo“Ogbanje” or “iyi-uwa”Similar to the Yoruba concept, involving spirit children believed to cause suffering before departing
IdomaNo specific name recordedClassed among diseases believed to be caused by evil spirits or misconduct; marriage between close relatives is considered an abomination associated with such disorders

These traditional conceptualisations demonstrate that Nigerian communities are not only aware of the syndrome but also recognise its chronicity, endemicity, and the challenges it presents to families. This understanding has shaped the development of specific management strategies, including herbal treatments that have been refined over generations.

3. NIPRISAN®: Nigeria’s Most Significant Herbal Antisickling Achievement

3.1 Development and Composition

The most scientifically well-documented and significant Nigerian herbal remedy for sickle cell anaemia is NIPRISAN® (now known as Nicosan®), developed by the National Institute for Pharmaceutical Research and Development (NIPRD) in Abuja. This formulation is based on a traditional Yoruba recipe and represents a landmark achievement in the integration of traditional medicine with modern pharmaceutical development.

The herbal components of NIPRISAN are derived from four plants:

PlantCommon NameTraditional Role
Eugenia caryophyllataClove (“Kanunfari” in Hausa)Pain relief, antimicrobial
Piper guineenseWest African black pepper (“Eche” in Idoma, “Uziza” in Igbo)Pain relief, digestive health
Pterocarpus osunAfrican rosewood (common in Osun State)Blood tonic, wound healing
Sorghum bicolorGuinea cornNutritional support, the leaf stalk yields an extract resembling blood

Before the development of NIPRISAN, these herbs were typically extracted either with “ogoro” (an ethanolic distillate of palm wine) or with an aqueous solution of trona (sodium sesquicarbonate, a mineral used in Nigeria as a food tenderiser).

3.2 Scientific Validation and Regulatory Approval

NIPRISAN has undergone rigorous scientific evaluation, establishing it as the most thoroughly studied herbal antimalarial in Nigeria:

  • Clinical Trials: The formulation completed Phases IIA and IIB clinical trials in Nigeria
  • Regulatory Approval: Received formal approval for use in Nigeria for the treatment of SCD in 2006
  • International Recognition: The US FDA determined sufficient safety and efficacy data to support a Phase III clinical trial
  • Global Reach: Widely used in Nigeria and known in India and the USA

3.3 Mechanisms of Action: Phytocannabinoids and Vanilloids

The therapeutic effects of NIPRISAN extend beyond simple antisickling activity. Research has revealed that compounds in E. caryophyllata and P. guineense may account for pain-relieving effects during sickle cell crises through interactions with vanilloid and cannabinoid receptors.

Vanilloids present in these plants include:

CompoundSourceEffect
EugenolClove (E. caryophyllata)Numbing analgesic effect; used in toothpaste formulations
PiperineWest African black pepper (P. guineense)Pain relief through counterirritation; produces endorphins
VanillinVarious sourcesFlavour compound

Eugenol’s fat solubility allows it to penetrate tissues and bind to lipid-rich membrane-bound vanilloid receptors, producing analgesic effects. Piperine and capsaicin interact with the same receptors, paradoxically causing initial burning sensations that ultimately lower pain sensitivity through endorphin release. People who consume significant amounts of pepper (as the Idoma and Yoruba do) build tolerance to these compounds, experiencing pleasurable endorphin-mediated well-being.

The cannabinoid β-caryophyllene, also present in clove, binds selectively to CB2 receptors, contributing to the anti-inflammatory and analgesic effects of the formulation.

4. Other Nigerian Herbal Remedies with Scientific Validation

4.1 Scientific Studies on Antisickling Activity

Recent research has provided scientific validation for numerous Nigerian plants used traditionally in SCD management:

Study from Sokoto, Nigeria (2024)

A study examining plants used by traditional medical professionals in Sokoto State evaluated the antisickling activity of five plants:

PlantAntisickling Activity (%)Key Findings
Khaya senegalensis95.29 ± 5.62%Highest reversal activity
Vernonia amygdalina92.19 ± 6.91%Strong membrane stabilisation
Cassia nigricans92.26 ± 5.01%IC₅₀ = 5.01 mg/mL for membrane stability
Ficus sycomorus92.11 ± 6.31%Significant activity
Ficus carica88.32 ± 3.98%Highest membrane stabilising potential (IC₅₀ = 3.98 mg/mL)

All extracts demonstrated high potency in maintaining erythrocyte membrane integrity and altering sickle cell haemoglobin polymerisation at increasing concentrations. Phytochemical screening revealed the presence of alkaloids, saponins, terpenes, and flavonoids, confirming the traditional use of these plants.

Combretum platypterum (2025)

A study evaluating the leaf and stem of Combretum platypterum reported for the first time its antisickling activity:

  • Inhibitory antisickling activity: Ethyl acetate fraction of the leaf methanol extract exhibited 89.8% inhibition
  • Reversal antisickling activity: n-Hexane fraction of the leaf showed 77.7% activity
  • Total phenolic content: 12.60 mg GAE/g in the most active fraction
  • Total flavonoid content: 17.62 mg QE/g in the n-hexane fraction

The study concluded that these findings provide scientific justification for the ethnomedicinal use of C. platypterum in sickle cell disease management.

Alchornea cordifolia (2014)

Christmas bush, widely distributed in Southeastern Nigeria, demonstrated profound antisickling effectiveness:

FractionInhibition of HbSS PolymerisationFe²⁺/Fe³⁺ Ratio Improvement
Water-soluble fraction (WAS)98.12% in 20 minutesRemarkable improvement
Fat-soluble fraction (FAS)47.50% in 20 minutesRemarkable improvement
Butanol-soluble fraction (BUS)47.50% in 20 minutesNo improvement

Phytochemical composition included:

ComponentContent (mg/100g)
Total Vitamin C1929.18 mg
Total Free Amino Acids (FAS)526.8 mg
Potassium150.30 mg
Sodium228.20 mg

The study concluded that the leaf extracts, with their preponderance of micro and macronutrients, vitamins, and amino acids, “may be very beneficial for the management of sickle cell disease”.

4.2 Three Native Nigerian Plants (Southeast)

Research on Ficus thonningii (FTH), Jatropha tanjorensis (JTR), and Justicia carnae (JCN) revealed preferential antisickling mechanisms:

PlantInhibition of Sickling (%)Polymerisation Inhibition (%)Membrane Protection (Haemolysis at 0.35% saline)
Ficus thonningii49.818 ± 0.082%76.888 ± 0.042%26.548 ± 0.056%
Jatropha tanjorensis41.001 ± 0.413%48.723 ± 0.113%18.055 ± 0.064%
Justicia carnae33.957 ± 0.062%75.447 ± 0.063%20.217 ± 0.035%
Hydroxyurea (control)30.414 ± 0.162%70.903 ± 0.150%14.459 ± 0.040%

These findings suggest the extracts contain potential antisickling phytochemicals that merit further exploration.

4.3 Tafafia: A Jos-Area Herbal Remedy

“Tafafia,” a herbal remedy used in the clinical management of sickle cell disease in the Jos area, demonstrated concentration-dependent antisickling activity:

ConcentrationSickling Inhibition (90 min)
0.8 µg/ml80.1%
0.1 µg/mlLower activity
Control (normal saline)36.0%

Preliminary phytochemical examination revealed the presence of alkaloids, saponins, and tannins, while anthraquinones were absent. The study confirmed “positive antisickling properties” supporting clinical use in the Jos area.

5. Ethnobotanical Surveys: Documentation of Nigerian Antisickling Plants

5.1 Plant Diversity in Traditional Use

Multiple ethnobotanical surveys have documented the rich diversity of Nigerian plants used for SCD management:

Kwara State Survey (2021)

A study in one rural and one urban local government area of Kwara State identified 57 plant species belonging to 34 families. The most prominent families were Fabaceae and Euphorbiaceae. Key plants by Use Mention Index (UMI) included:

PlantFamilyUse Mention Index (UMI)
Elaeis guineenseArecaceae0.124
Khaya grandifoliolaMeliaceae0.094
Carica papayaCaricaceae0.094
Hymenocardia acidaPhyllanthaceae0.094
Mangifera indicaAnacardiaceae0.094
Parquetina nigrescensAsclepiadaceae0.094
Xylopia aethiopicaAnnonaceae0.094

Ekiti State Survey (2015)

A survey of 32 traditional medical practitioners in Gbonyin Local Government Area identified 44 plant species belonging to 44 genera and 30 families. The most prominent families were:

FamilyGenera Represented
AnacardiaceaeAnacardium occidentalis, Mangifera indica, Spondias mombin
EuphorbiaceaeCroton lobatus, Jatropha gossypifolia, Plukeneta conophora
FabaceaeCajanus cajan, Pterocarpus osun, Cassia siamea

Key findings from the survey:

  • 80% of respondents reported no side effects from herbal remedies
  • Main preparation method: Decoction
  • Dosage: Usually taken orally twice to thrice daily
  • Herb sources: Collected from the forest or purchased from herb markets

Dutsin-Ma, Katsina State (2024)

An ethnobotanical survey identified 32 species of medicinal plants from 20 families used for management of common ailments including sickle cell anaemia. The study concluded that “traditional medicinal plants provide the alternative therapy for treatment and management of diseases to significant number of people” and that “herbal practitioners are still relevant to African healthcare system”.

5.2 Commonly Used Antisickling Plants

Based on the available literature, a selection of frequently used Nigerian antisickling plants includes:

Plant NameCommon NamePart UsedScientific Evidence Level
Vernonia amygdalinaBitter leafLeavesHigh (92.19% reversal activity)
Khaya senegalensisAfrican mahoganyBarkHigh (95.29% reversal activity)
Ficus caricaFigStem barkHigh (88.32% reversal, best membrane stability)
Alchornea cordifoliaChristmas bushLeavesHigh (98.12% inhibition)
Pterocarpus osunAfrican rosewoodBarkModerate (Component of NIPRISAN)
Cajanus cajanPigeon peaLeavesModerate (Traditional use documented)
Carica papayaPawpawLeavesModerate (UMI 0.094)
Xylopia aethiopicaWest African pepperFruitsModerate (UMI 0.094)
Mangifera indicaMangoBarkModerate (UMI 0.094)
Spondias mombinYellow mombinBarkDocumented use

6. Nutraceuticals: A Complementary Approach

6.1 Scientific Evidence from Nigeria

A retrospective study in Abuja evaluated a cohort of 10 children with sickle cell anaemia placed on a cocktail of nutraceuticals. Aroga immune support was the most common component. The results showed significant improvements at six months:

ParameterBaselineAt 6 MonthsStatistical Significance
Average weight21.8 kg23.0 kgp=0.236 (not significant)
Average haematocrit22.8%27.2%p=0.011 (significant)
Average frequency of crises7.4 episodes3.2 episodesp=0.011 (significant) 

Clinical outcomes:

  • 8 out of 10 children showed moderate to good clinical improvement
  • No adverse reactions documented in any child
  • Overall clinical profile: moderate category

6.2 Potential Mechanisms

Nutraceuticals may work through multiple mechanisms:

  • Omega-3 fatty acids (e.g., DHA from fish) improve RBC flexibility and reduce irreversibly sickled cells by up to 40% in animal models
  • Nutritional support addresses the increased metabolic demands of chronic haemolysis
  • Antioxidant effects reduce oxidative stress associated with sickling

The study authors concluded that “the use of nutraceuticals may be beneficial in the management of sickle cell anaemia in children” but emphasised that “the results are preliminary and will require stronger evidence”.

7. Non-Pharmacological Interventions: Adolescent Perspectives

7.1 Survey Findings

A population-based survey exploring non-pharmacological interventions (NPIs) for sickle cell crisis pain management among Nigerian adolescents (aged 12-18) revealed widespread use of complementary approaches:

FindingPercentage/Number
Participants who had used at least one NPI77%
Total NPIs reported31 different types
Average pain intensity during last crisis (out of 10)6.6
Mean number of crises in past year4.53 episodes

7.2 Most Commonly Used NPIs

NPIPast Use (%)Future Plan to Use (%)
Massage53%33%
Herbal products37%45%
Prayer30%30%
Heat application20%Not specified

Reasons for NPI use included:

  • “To feel better” (49%)
  • “To prevent the pain from getting worse” (37%)
  • First aid purposes (9%)

Reasons for NOT using NPI:

  • “The healthcare team did not recommend it” (38%)
  • Caregiver disapproval (8%)

7.3 Implications

The high prevalence of NPI use (77%) despite limited scientific evidence warrants attention. The study highlighted “an urgent need to further explore the specific NPIs used and their effectiveness on SCD outcomes and safety”. Adolescents also expressed preference for receiving NPI education via videos (34%) and animations (20%).

8. Faith Healing and Spiritual Interventions

8.1 Faith Healing Techniques

A qualitative study in Osun State examined faith healing techniques in SCD management outside medical settings. Key findings included:

Treatment techniques employed:

Christian/Muslim ClericsTraditional Healers
PrayerDivination
FastingHerbs and charms
CounsellingAppeasement of spirits believed to cause the disease

Key observations:

  • Both Christian and Muslim clerics recognise the need for modern medical services alongside faith interventions
  • Muslim clerics also use herbs in their practice
  • Emotional trauma was identified as a major threat to treatment adherence
  • Prayer and fasting were considered effective for addressing this emotional trauma
  • Combination of faith healing, spiritual consultation, and modern medicine represents the general treatment trend

8.2 Cultural Context

The study concluded that “culture and society provide the context for understanding the prevention and treatment of diseases.” The integration of faith healing with other approaches reflects the complex healthcare-seeking behaviour of Nigerian populations.

9. Herbal Medicine Preparation and Administration

9.1 Common Preparation Methods

Based on ethnobotanical surveys, the predominant preparation methods for Nigerian antisickling herbs are:

MethodDescriptionPrevalence
DecoctionBoiling plant material in waterMost common method
InfusionSteeping in hot water (like tea)Common for leaves
MacerationSoaking in cold water or solventsUsed for delicate parts
Powdered formulationsDried plant material ground and encapsulatedUsed for some formulations

9.2 Plant Parts Used

According to surveys across multiple states:

  • Leaves form the major part of plant materials used
  • Bark and roots are also commonly used
  • In some formulations, fruits and seeds are utilised

10. Safety Considerations and Clinical Implications

10.1 Key Safety Concerns

ConcernImplication
Lack of standardisationVariable potency and possible contamination
Potential toxicitySome plants may be hepatotoxic or nephrotoxic at high doses
Drug interactionsHerbal remedies may interact with hydroxyurea or other medications
Limited safety dataMost evidence focuses on efficacy rather than safety
Disclosure issuesHealthcare providers may not be aware of concurrent herbal use

10.2 Healthcare Provider Challenges

The survey of adolescents revealed that healthcare providers often disapprove of NPI use, yet patients continue using them. This creates a communication gap between patients and providers, preventing:

  • Assessment of potential interactions
  • Monitoring for adverse effects
  • Evidence-based guidance on safe complementary therapy

10.3 Recommendations

Based on the literature, the following recommendations are suggested:

For Patients:

  • Disclose all herbal and NPI use to healthcare providers
  • Use products from reputable sources where possible
  • Monitor for adverse effects and report immediately
  • Maintain conventional treatment (hydroxyurea, folic acid, antimalarials)
  • Seek guidance before combining multiple therapies

For Healthcare Providers:

  • Ask about herbal and NPI use during consultations
  • Provide culturally sensitive, evidence-based guidance
  • Monitor patients for interactions and adverse effects
  • Document complementary therapy use
  • Support research on safety and efficacy of NPIs

For Researchers:

  • Conduct controlled clinical trials on commonly used herbs
  • Evaluate safety profiles for chronic use
  • Study drug interactions with standard medications
  • Identify and characterise active compounds

11. Research Gaps and Future Directions

11.1 Key Research Needs

AreaPriority
Human clinical trialsMost evidence from in vitro and animal models
Long-term safety studiesChronic use effects on liver, kidney, other organs
Drug interaction studiesInteractions with hydroxyurea, antibiotics, antimalarials
Standardised dosing protocolsDefined dosing for herbal formulations
Pharmacokinetic studiesAbsorption, distribution, metabolism, elimination
Combination therapy studiesHerbal + conventional treatment interactions
Quality control methodsAffordable quality assurance methods

11.2 Opportunities

  • Development of simplified NIPRISAN formulations: The US FDA suggested a simpler formulation with chemical fingerprinting and elucidation of active compounds
  • Functional foods: Edible plants with antisickling properties could be developed for prevention
  • Cannabinoid/vanilloid research: Further investigation of pain relief mechanisms
  • Nutraceutical development: Standardised nutritional supplements for SCD management

12. Conclusion

Nigeria bears the greatest burden of sickle cell disease globally, with approximately 150,000 new cases annually. The management of this chronic condition has been significantly influenced by traditional medicine, which remains deeply embedded in Nigerian healthcare practices, particularly in rural communities where conventional treatments are often inaccessible or unaffordable.

The scientific validation of Nigerian herbal remedies has progressed considerably:

  • NIPRISAN® represents the most significant achievement, developed from a traditional Yoruba recipe and approved for use in Nigeria since 2006, with US FDA clearance for Phase III trials
  • Multiple scientific studies have validated antisickling activities of Nigerian plants including Khaya senegalensis (95.29% reversal activity), Vernonia amygdalina (92.19%), Alchornea cordifolia (98.12% inhibition), and Combretum platypterum (89.8%)
  • Nutraceuticals have demonstrated potential benefits, with significant improvements in haematocrit (22.8% to 27.2%) and crisis frequency (7.4 to 3.2 episodes) over six months
  • Non-pharmacological interventions including massage, prayer, and heat application are used by 77% of adolescents with SCD to manage crisis pain

However, challenges remain:

  • Limited human clinical trial data for most remedies
  • Safety concerns including potential drug interactions
  • Disclosure gaps between patients and healthcare providers
  • Lack of standardisation for many herbal products

The path forward requires:

  1. Acknowledging and respecting traditional knowledge while subjecting it to rigorous scientific scrutiny
  2. Strengthening regulatory oversight of herbal products through NAFDAC
  3. Promoting open communication between patients and healthcare providers
  4. Investing in clinical research on safety, efficacy, and mechanisms of action
  5. Developing integration strategies that combine the best of both systems
  6. Preserving and documenting indigenous knowledge before it is lost

As Nigeria continues its fight against sickle cell anaemia, the careful integration of evidence-based traditional medicine into the healthcare system offers promising strategies for improving the quality of life of those living with this challenging condition.

13. References

  1. Ameh SJ, Tarfa FD, Ebeshi BU. Traditional Herbal Management of Sickle Cell Anemia: Lessons from Nigeria. Anemia. 2012;2012:607436.
  2. Fashetan MO, Ajayi TO, Adeyemi AA, Fasola FA, Ogunmefun AS, Moody JO. In vitro evaluation of the antisickling activities of leaf and stem of Combretum platypterum (Welw.) Hutch. & Dalziel. Nigerian Journal of Natural Products and Medicine. 2025;28(1).
  3. Lawal MO, Akinrinde OO, Jegede AS. Faith Healing Techniques in the Management of Sickle Cell Anaemia in Nigeria. Global Social Welfare. 2024; Springer.
  4. Lawal BA, Moody JO. Ethnobotanical Survey of Plants used in the Management of Sickle Cell Disease in Two Local Government Areas of Kwara State, North-Central Nigeria. The Nigerian Journal of Pharmacy. 2017;51(1).
  5. The Effects of Extracts of Christmas Bush (Alchornea cordefolia) on Sickle Cell Hemoglobin. IMSEAR. 2014.
  6. Ayuba SA, Onu A. Phytochemical Analysis and Antisickling Activity of some Medicinal Plants from Sokoto, Nigeria. UMYU Scientifica. 2024;3(3).
  7. Awor S, Bongomin F, Kaggwa MM, Pebalo FP, Musoke D. Prevalence of Use of Herbal Medicines for the Treatment of Sickle Cell Disease in Africa: A Systematic Review and Meta-analysis. Journal of Herbal Medicine. 2023;100735.
  8. Adolescents’ perspectives on non-pharmacological pain interventions for sickle cell crisis management: A population-based survey. PLoS ONE. 2025;20(8):e0330127.
  9. Famojuro TI, Moody JO. Survey of Medicinal Plants Used in the Management of Sickle Cell Disease by Traditional Medical Practitioners of Gbonyin Local Government Area of Ekiti State, Nigeria. Nigerian Journal of Natural Products and Medicine. 2015;19.
  10. Ijoma KI, Ajiwe VIE, Ndubuisi JO. Evidence-Based Preferential In Vitro Antisickling Mechanism of Three Native Nigerian Plants Used in the Management of Sickle Cell Disease. Malaysian Journal of Biochemistry & Molecular Biology. 2022;3:9-17.
  11. Sadiq IZ, Abubakar FS, Ibrahim B, Usman MA, Kudan ZB. Medicinal plants for management and alternative therapy of common ailments in Dutsin-Ma (Katsina State) in Nigeria. AGRIS/FAO. 2024.
  12. The Anti-sickling and Pharmacognostic evaluation of Tafafia – A herbal Remedy used in Management of Sickle Cell in Nigeria. African Journal of Biomedical Research. 2024;12(2):153-155.
  13. Preliminary Report on the Use of Nutraceuticals in the Management of Sickle Cell Anemia: A Case Series. PMC. 2024;21(3):89-95.